Answers are grounded in this paper and cite their sources.
Adolescents and young adults frequently receive chemotherapy near death. We know less about the use of targeted agents and immunotherapy or trends over time.
No takes yet. Share an insight, caveat, or question.
Mack et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: